Kawaguchi-Suzuki M[au] - Search Results

Year	Number of Results
2013	3
2014	3
2016	1
2017	3
2018	3
2019	4
2020	2
2021	2
2022	1
2023	1

1

Pharmacokinetic Considerations in Amputees.

Elbarbry F, Nguyen V, Kawaguchi-Suzuki M. Elbarbry F, et al. Among authors: kawaguchi suzuki m. J Pharm Pract. 2021 Oct;34(5):794-799. doi: 10.1177/0897190020942659. Epub 2020 Jul 29. J Pharm Pract. 2021. PMID: 32723146 Review.

2

Cultural Sensitivity and Global Pharmacy Engagement in the United States.

Alsharif NZ, Khanfar NM, Brennan LF, Chahine EB, Law M, Parekh J, Kawaguchi-Suzuki M, Hogue MD. Alsharif NZ, et al. Among authors: kawaguchi suzuki m. Am J Pharm Educ. 2019 May;83(4):7220. doi: 10.5688/ajpe7220. Am J Pharm Educ. 2019. PMID: 31223165 Free PMC article. Review.

3

Characteristics of Successful International Pharmacy Partnerships.

Prescott GM, Jonkman L, Crutchley RD, Dey S, Hong LT, Malhotra J, Seo SW, Kawaguchi-Suzuki M, Truong HA, Unni E, Tsuchihashi K, Forkan N, Abrons JP. Prescott GM, et al. Among authors: kawaguchi suzuki m. Pharmacy (Basel). 2023 Jan 1;11(1):7. doi: 10.3390/pharmacy11010007. Pharmacy (Basel). 2023. PMID: 36649017 Free PMC article.

4

Baseline Assessment of Systemic Racism Education in Pharmacy Curricula.

Tupas KD, Campbell HE, Lewis TL, Leslie KF, McGee EU, Blakely ML, Kawaguchi-Suzuki M. Tupas KD, et al. Among authors: kawaguchi suzuki m. Am J Pharm Educ. 2022 Apr 25:9028. doi: 10.5688/ajpe9028. Online ahead of print. Am J Pharm Educ. 2022. PMID: 35470174

5

Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia.

Maxwell WD, Ramsey LB, Johnson SG, Moore KG, Shtutman M, Schoonover JH, Kawaguchi-Suzuki M. Maxwell WD, et al. Among authors: kawaguchi suzuki m. Pharmacotherapy. 2017 Sep;37(9):1172-1190. doi: 10.1002/phar.1981. Epub 2017 Aug 23. Pharmacotherapy. 2017. PMID: 28672099 Review.

6

The role of pharmacogenetics in the treatment of chronic hepatitis C infection.

Kawaguchi-Suzuki M, Frye RF. Kawaguchi-Suzuki M, et al. Pharmacotherapy. 2014 Feb;34(2):185-201. doi: 10.1002/phar.1349. Epub 2013 Sep 30. Pharmacotherapy. 2014. PMID: 24114761 Review.

7

Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis.

Kawaguchi-Suzuki M, Bril F, Kalavalapalli S, Cusi K, Frye RF. Kawaguchi-Suzuki M, et al. Aliment Pharmacol Ther. 2017 Jul;46(1):56-61. doi: 10.1111/apt.14111. Epub 2017 May 3. Aliment Pharmacol Ther. 2017. PMID: 28470881 Free PMC article.

8

Current clinical evidence on pioglitazone pharmacogenomics.

Kawaguchi-Suzuki M, Frye RF. Kawaguchi-Suzuki M, et al. Front Pharmacol. 2013 Nov 26;4:147. doi: 10.3389/fphar.2013.00147. eCollection 2013. Front Pharmacol. 2013. PMID: 24324437 Free PMC article.

9

Reconsidering Sports Pharmacists and Anti-Doping Education as the World Celebrates the Olympic and Paralympic Games.

Kawaguchi-Suzuki M, Anderson A, Suzuki S. Kawaguchi-Suzuki M, et al. Am J Pharm Educ. 2021 Aug;85(7):8695. doi: 10.5688/ajpe8695. Epub 2021 May 4. Am J Pharm Educ. 2021. PMID: 34544745 Free PMC article.

10

COVID-19 Pandemic Challenges and Lessons Learned by Pharmacy Educators Around the Globe.

Kawaguchi-Suzuki M, Nagai N, Akonoghrere RO, Desborough JA. Kawaguchi-Suzuki M, et al. Am J Pharm Educ. 2020 Aug;84(8):ajpe8197. doi: 10.5688/ajpe8197. Am J Pharm Educ. 2020. PMID: 32934392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results